Ankylosing Spondylitis

Assessing Diagnostic Challenges in Axial Spondyloarthritis

Assessing Diagnostic Challenges in Axial Spondyloarthritis

By

Axial spondyloarthritis is often delayed or missed as a diagnosis, leading to poor long-term outcomes and decreased quality of life.

Pelvic Orientation From Standing to Sitting Adjusted by Global Spinal Alignment in AS

Pelvic Orientation From Standing to Sitting Adjusted by Global Spinal Alignment in AS

By

Pelvic orientation was adjusted by global spinal alignment in patients with ankylosing spondylitis.

Work Instability Linked to Fatigue, Depression in Ankylosing Spondylitis

Work Instability Linked to Fatigue, Depression in Ankylosing Spondylitis

By

Fatigue and depressive symptoms had a negative effect on work stability in patients with ankylosing spondylitis.

Acute Anterior Uveitis Incidence Reduced With Golimumab in Ankylosing Spondylitis

Acute Anterior Uveitis Incidence Reduced With Golimumab in Ankylosing Spondylitis

By

Researchers observed a significant reduction in the incidence of acute anterior uveitis among patients with ankylosing spondylitis treated with golimumab.

CRP Levels May Predict Treatment Response in Ankylosing Spondylitis

CRP Levels May Predict Treatment Response in Ankylosing Spondylitis

By

C-reactive protein levels may be an effective predictive measure to assess treatment response in patients with ankylosing spondylitis.

Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis

Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis

By

The TORTUGA trial investigated the efficacy and safety of filgotinib for the treatment of patients with active ankylosing spondylitis.

Clinical Characteristics of Patients With AS Who Discontinue TNFis Explored

Clinical Characteristics of Patients With AS Who Discontinue TNFis Explored

By

To compare the characteristics of patients who discontinued TNFis with those who did not, researchers used the Corrona PsA/SpA Registry to identify patients with AS who were on a TNFi and had ≥2 follow-up visits.

Differences in Ankylosing Spondylitis Outcomes Vary by Gender

Differences in Ankylosing Spondylitis Outcomes Vary by Gender

By

Clinical improvements during treatment with TNF-α inhibitors was comparable between men and women with ankylosing spondylitis.

Sustained Improvements in Quality of Life With Secukinumab in Ankylosing Spondylitis

Sustained Improvements in Quality of Life With Secukinumab in Ankylosing Spondylitis

By

Treatment with secukinumab 150 mg provides significant, clinically meaningful, and sustained improvement in health-related quality of life among patients with ankylosing spondylitis.

Genetic Risk Score May Lead to Earlier Ankylosing Spondylitis Diagnosis

Genetic Risk Score May Lead to Earlier Ankylosing Spondylitis Diagnosis

By

The genetic risk score may have lower costs than current testing methods.

Greater Entheseal Damage, Inflammation Observed in Psoriatic Arthritis vs Ankylosing Spondylitis

Greater Entheseal Damage, Inflammation Observed in Psoriatic Arthritis vs Ankylosing Spondylitis

By

Patients with psoriatic arthritis had greater entheseal insertion damage scores compared with patients with ankylosing spondylitis.

Hospitalized Infection Risk Not Linked to DMARD, TNFi Use in Ankylosing Spondylitis

Hospitalized Infection Risk Not Linked to DMARD, TNFi Use in Ankylosing Spondylitis

By

No clear evidence links the risk for hospitalized infection and the use of DMARDs or anti-TNF agents in patients with ankylosing spondylitis.

Risk for Total Knee Arthroplasty Elevated in Ankylosing Spondylitis

Risk for Total Knee Arthroplasty Elevated in Ankylosing Spondylitis

By

The risk for primary total knee arthroplasty is elevated in young and middle-aged adults with ankylosing spondylitis.

Assessment of Simultaneous Occurrence of Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis

Assessment of Simultaneous Occurrence of Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis

By

Researchers explored the co-occurrence of ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis.

TNFi Effectively Decreases Radiographic Progression in Early Ankylosing Spondylitis

TNFi Effectively Decreases Radiographic Progression in Early Ankylosing Spondylitis

By

Effective suppression of inflammation with tumor necrosis factor inhibitor therapy decreases radiographic progression in early ankylosing spondylitis.

Rates of Knee, Hip Arthroplasty Increasing Among Patients With Ankylosing Spondylitis

Rates of Knee, Hip Arthroplasty Increasing Among Patients With Ankylosing Spondylitis

By

Researchers observed increased rates of both knee and hip arthroplasties in older patients with ankylosing spondylitis.

Lower Cardiorespiratory Fitness Associated With Increased CVD Risk in Ankylosing Spondylitis

Lower Cardiorespiratory Fitness Associated With Increased CVD Risk in Ankylosing Spondylitis

By

Reduced cardiorespiratory fitness may be associated with increased risk for CVD in ankylosing spondylitis.

Risankizumab May Not Be Effective in Treatment of Ankylosing Spondylitis

Risankizumab May Not Be Effective in Treatment of Ankylosing Spondylitis

By

Treatment with risankizumab was not effective in reducing the signs and symptoms of ankylosing spondylitis at 12 weeks.

Positive Phase 3 Data Announced for Ixekizumab in Ankylosing Spondylitis

Positive Phase 3 Data Announced for Ixekizumab in Ankylosing Spondylitis

By

Results from a phase 3 study show positive results for ixekizumab in patients with ankylosing spondylitis.

Ankylosing Spondylitis Linked to Increased Prevalence of Left Ventricular Hypertrophy

Ankylosing Spondylitis Linked to Increased Prevalence of Left Ventricular Hypertrophy

By

Data strengthen the indication for performing a thorough CVD risk assessment in patients with inflammatory disorders.

Fatigue Affects Work Disability in Rheumatoid Arthritis, Ankylosing Spondylitis

Fatigue Affects Work Disability in Rheumatoid Arthritis, Ankylosing Spondylitis

By

Fatigue had a significant and independent effect on work disability measures in rheumatoid arthritis and ankylosing spondylitis.

Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic Characteristics

Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic Characteristics

By

It is unclear whether ankylosing spondylitis and axial psoriatic arthritis are part of a spectrum of the same disease, or whether they are separate diseases with overlapping features.

NSAID, TNFi Combination May Reduce Radiographic Progression in Ankylosing Spondylitis

NSAID, TNFi Combination May Reduce Radiographic Progression in Ankylosing Spondylitis

By

Dose-related use of NSAIDs together with TNFi in patients with ankylosing spondylitis has a synergistic effect in slowing radiographic progression.

Bimekizumab Linked to 12-Week Clinical Improvements in Ankylosing Spondylitis

Bimekizumab Linked to 12-Week Clinical Improvements in Ankylosing Spondylitis

By

Investigators assessed the 12-week efficacy and safety of bimekizumab in patients with active ankylosing spondylitis.

Biologic Therapy in Ankylosing Spondylitis: Insights From Social Media

Biologic Therapy in Ankylosing Spondylitis: Insights From Social Media

By

Researchers used data from social media to identify concerns and perceptions regarding biologic therapies.

Tofacitinib Reduces MRI Inflammation, May Improve Outcomes in Ankylosing Spondylitis

Tofacitinib Reduces MRI Inflammation, May Improve Outcomes in Ankylosing Spondylitis

By

Researchers assessed achievement of minimally important changes in SPARCC scores in biologic-naive patients with ankylosing spondylitis treated with tofacitinib or placebo.

Factors Associated With Neuropathic Pain in Ankylosing Spondylitis

Factors Associated With Neuropathic Pain in Ankylosing Spondylitis

By

A number of factors that include age, the presence of enthesitis, and depressive symptoms may be associated with neuropathic pain in ankylosing spondylitis.

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

By

Researchers sought to provide information on pregnancy outcomes, including major congenital malformations and other maternal and fetal adverse outcomes, in women treated with certolizumab pegol.

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

By

Nonmandatory transitioning from originator etanercept to biosimilar etanercept SB4 using a specifically designed communication strategy showed a slightly lower persistence rate and smaller decreases in disease activity.

TNF Inhibitors Reduce Long-Term Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis

TNF Inhibitors Reduce Long-Term Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis

By

TNFi therapy yielded favorable results in patients with AS or PsA, with progressively better responses between 4 months and 3 years.

Sign Up for Free e-newsletters